Table 1 Patient baseline characteristics

 Mean age (years)

74.4 ± 7.6

 Male, n (%)

35 (68.6)

 CHA₂DS₂-VASc score

3.2 ± 1.5

 HAS-BLED score

3.1 ± 1.1

 Body mass index (kg/m²)

28.8 ± 5.7

 Atrial fibrillation persistent or permanent, n (%)

40 (78.4)

 Previous bleeding complication, n (%)

24 (47.1)

  • Intracranial bleeding, n (%)

3 (5.9)

  • Gastrointestinal bleeding, n (%)

13 (25.5)

  • Other bleeding, n (%)

8 (15.7)

 High bleeding risk, n (%)

26 (51.0)

 Other limitation to oral anticoagulation therapy, n (%)

1 (2.0)

 Interventricular septum thickness (IVS), mm

10.4 ± 1.5

 Left ventricular ejection fraction (LVEF), %

49.5 ± 12.2

 Mitral regurgitation, n (%)

  no or mild

38 (74.5)

  moderate

13 (25.5)

  severe

0

 Beta-blocker

20 (39.2)

 ACE inhibitor/AT-blocker

23 (45.1)

 Loop diuretic

32 (62.7)